Miracll ChemicalsLtd Balance Sheet Health

Financial Health criteria checks 3/6

Miracll ChemicalsLtd has a total shareholder equity of CN¥1.5B and total debt of CN¥1.2B, which brings its debt-to-equity ratio to 79.4%. Its total assets and total liabilities are CN¥3.8B and CN¥2.3B respectively. Miracll ChemicalsLtd's EBIT is CN¥40.1M making its interest coverage ratio -2.2. It has cash and short-term investments of CN¥534.0M.

Key information

79.4%

Debt to equity ratio

CN¥1.20b

Debt

Interest coverage ratio	-2.2x
Cash	CN¥533.97m
Equity	CN¥1.52b
Total liabilities	CN¥2.33b
Total assets	CN¥3.85b

Recent financial health updates

Miracll ChemicalsLtd (SZSE:300848) Takes On Some Risk With Its Use Of Debt

Nov 16

Here's Why Miracll ChemicalsLtd (SZSE:300848) Has A Meaningful Debt Burden

Jul 13

Recent updates

Miracll ChemicalsLtd (SZSE:300848) Takes On Some Risk With Its Use Of Debt

Nov 16

Miracll Chemicals Co.,Ltd (SZSE:300848) Stocks Shoot Up 41% But Its P/S Still Looks Reasonable

Oct 09

Here's Why Miracll ChemicalsLtd (SZSE:300848) Has A Meaningful Debt Burden

Jul 13

Miracll ChemicalsLtd (SZSE:300848) Has Announced A Dividend Of CN¥0.10

May 26

Miracll Chemicals Co.,Ltd's (SZSE:300848) 26% Jump Shows Its Popularity With Investors

May 22

Miracll ChemicalsLtd's (SZSE:300848) Anemic Earnings Might Be Worse Than You Think

Apr 29

Market Participants Recognise Miracll Chemicals Co.,Ltd's (SZSE:300848) Earnings Pushing Shares 29% Higher

Mar 29

Financial Position Analysis

Short Term Liabilities: 300848's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥1.1B).

Long Term Liabilities: 300848's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥1.2B).

Debt to Equity History and Analysis

Debt Level: 300848's net debt to equity ratio (44.2%) is considered high.

Reducing Debt: 300848's debt to equity ratio has increased from 0% to 79.4% over the past 5 years.

Debt Coverage: 300848's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: 300848 earns more interest than it pays, so coverage of interest payments is not a concern.

Miracll ChemicalsLtd Balance Sheet Health

Financial Health criteria checks 3/6

Key information

Recent financial health updates

Miracll ChemicalsLtd (SZSE:300848) Takes On Some Risk With Its Use Of Debt

Here's Why Miracll ChemicalsLtd (SZSE:300848) Has A Meaningful Debt Burden

Recent updates

Miracll ChemicalsLtd (SZSE:300848) Takes On Some Risk With Its Use Of Debt

Third quarter 2024 earnings released: EPS: CN¥0.04 (vs CN¥0.046 in 3Q 2023)

New major risk - Financial position

Miracll Chemicals Co.,Ltd (SZSE:300848) Stocks Shoot Up 41% But Its P/S Still Looks Reasonable

Miracll Chemicals Co.,Ltd to Report Q3, 2024 Results on Oct 25, 2024

Second quarter 2024 earnings released: EPS: CN¥0.05 (vs CN¥0.069 in 2Q 2023)

Here's Why Miracll ChemicalsLtd (SZSE:300848) Has A Meaningful Debt Burden

Miracll Chemicals Co.,Ltd to Report First Half, 2024 Results on Aug 27, 2024

Miracll ChemicalsLtd (SZSE:300848) Has Announced A Dividend Of CN¥0.10

Dividend of CN¥0.10 announced

Miracll Chemicals Co.,Ltd's (SZSE:300848) 26% Jump Shows Its Popularity With Investors

Miracll ChemicalsLtd's (SZSE:300848) Anemic Earnings Might Be Worse Than You Think

New minor risk - Profit margin trend

First quarter 2024 earnings released: EPS: CN¥0.04 (vs CN¥0.08 in 1Q 2023)

Miracll Chemicals Co.,Ltd, Annual General Meeting, May 15, 2024

Miracll Chemicals Co.,Ltd to Report Q1, 2024 Results on Apr 23, 2024

Market Participants Recognise Miracll Chemicals Co.,Ltd's (SZSE:300848) Earnings Pushing Shares 29% Higher

Investor sentiment improves as stock rises 19%

Investor sentiment deteriorates as stock falls 17%

Miracll Chemicals Co.,Ltd to Report Fiscal Year 2023 Results on Apr 23, 2024

New minor risk - Shareholder dilution

Third quarter 2023 earnings released: EPS: CN¥0.06 (vs CN¥0.08 in 3Q 2022)

Miracll Chemicals Co.,Ltd to Report Q3, 2023 Results on Oct 24, 2023

Second quarter 2023 earnings released: EPS: CN¥0.09 (vs CN¥0.11 in 2Q 2022)

Miracll Chemicals Co.,Ltd Approves Cash Dividend for the Year 2022

First quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.11 in 1Q 2022)

Investor sentiment improves as stock rises 28%

Investor sentiment improved over the past week

High number of new and inexperienced directors

Miracll Chemicals Co.,Ltd announced that it expects to receive CNY 234.999984 million in funding

Third quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.15 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.11 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.11 in 1Q 2021)

High number of new and inexperienced directors

Miracll Chemicals Co.,Ltd Announces Final Profit Distribution for 2021, Payable on 22 April 2022

Miracll Chemicals Co.,Ltd Approves Cash Dividend

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.093 loss in 3Q 2020)

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.27 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Miracll Chemicals Co.,Ltd Announces Profit Distribution Proposal for 2020

Full year 2020 earnings released: EPS CN¥1.79 (vs CN¥1.67 in FY 2019)

New 90-day high: CN¥59.70

Miracll Chemicals Co.,Ltd to Report Fiscal Year 2020 Results on Mar 16, 2021

New 90-day low: CN¥45.94

New 90-day high: CN¥63.50

Market bids up stock over the past week

Third quarter earnings released

Miracll Chemicals Co.,Ltd to Report Q3, 2020 Results on Oct 20, 2020

First half earnings released

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Discover healthy companies